Video

In Conversation with Charles River

A year on from the announcement of our strategic partnership with Charles River, we sat down with Dr Marijn Vlaming, Head of Biology, to discuss how ioCells are accelerating drug discovery and early-stage development.
Discover our ioCells portfolio
In Conversation with Charles River

Dr Marijn Vlaming

Head of Biology

Charles River Laboratories

A year on from the announcement of our strategic partnership with Charles River, we sat down with Dr Marijn Vlaming, Head of Biology, to discuss how ioCells are accelerating drug discovery and early-stage development.
In Conversation with Charles River

Dr Marijn Vlaming

Head of Biology

Charles River Laboratories

bit.bio and Charles River have partnered for translational drug development. Learn how you can screen and profile at Charles River with bit.bio ioCells.

Find out how ioCells can accelerate your drug discovery:

  • ioCells arrive at your lab with minimal batch to batch variation providing high reproducibility
  • ioCells accelerate drug discovery as they rapidly mature and are ready for experimentation within days
  • Using our two-step protocol means less time being spent on cell culture and more time gaining results
Discover our ioCells portfolio

Dr Marijn Vlaming

Charles River

2021

Related pages

News Read our latest updates and press coverage
Our platform Discover the cell identity coding platform behind our cells
Join us Explore the latest roles at bit.bio